Hyoscine butylbromide induced psychosis: A case report

Area of Science:

• Pediatric Neurology
• Clinical Toxicology

Background:

• Hyoscine butylbromide is a common anticholinergic medication used for abdominal pain.
• Psychosis is a rare but serious adverse effect associated with anticholinergic drugs.

Observation:

• A 9-year-old child presented with acute deterioration of cognitive functions.
• The child exhibited psychotic features, including altered perception and thought processes.
• The patient was concurrently taking hyoscine butylbromide for non-specific abdominal pain.

Findings:

• The clinical presentation suggested a diagnosis of hyoscine butylbromide-induced psychosis.
• This case highlights the potential for acute neuropsychiatric adverse events with this medication in pediatric patients.

Implications:

• Clinicians should consider hyoscine butylbromide-induced psychosis in the differential diagnosis of acute cognitive and psychotic disturbances in children.
• Awareness of this rare adverse effect is crucial for timely diagnosis and management.
• Further research may be warranted to understand the mechanisms and risk factors for this rare reaction.